JP2005508944A5 - - Google Patents

Info

Publication number

JP2005508944A5

JP2005508944A5 JP2003533961A JP2003533961A JP2005508944A5 JP 2005508944 A5 JP2005508944 A5 JP 2005508944A5 JP 2003533961 A JP2003533961 A JP 2003533961A JP 2003533961 A JP2003533961 A JP 2003533961A JP 2005508944 A5 JP2005508944 A5 JP 2005508944A5

Authority

JP

Japan

Prior art keywords

disorders

relaxin

treatment

human

medicament according

Prior art date

2002-10-02

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 46
• 239000003814 drug Substances 0.000 claims description 32
• 108090000103 Relaxin Proteins 0.000 claims description 29
• 102000003743 Relaxin Human genes 0.000 claims description 29
• 208000035475 disorder Diseases 0.000 claims description 24
• 201000010099 disease Diseases 0.000 claims description 22
• 206010028980 Neoplasm Diseases 0.000 claims description 13
• 230000006378 damage Effects 0.000 claims description 13
• 201000004384 Alopecia Diseases 0.000 claims description 12
• 206010016654 Fibrosis Diseases 0.000 claims description 12
• 231100000360 alopecia Toxicity 0.000 claims description 12
• 230000004761 fibrosis Effects 0.000 claims description 12
• 210000003734 kidney Anatomy 0.000 claims description 11
• 208000017169 kidney disease Diseases 0.000 claims description 11
• 238000004519 manufacturing process Methods 0.000 claims description 11
• 208000019901 Anxiety disease Diseases 0.000 claims description 10
• 208000020401 Depressive disease Diseases 0.000 claims description 10
• 208000026139 Memory disease Diseases 0.000 claims description 10
• 208000027418 Wounds and injury Diseases 0.000 claims description 10
• 208000014674 injury Diseases 0.000 claims description 10
• 208000017701 Endocrine disease Diseases 0.000 claims description 9
• 208000018262 Peripheral vascular disease Diseases 0.000 claims description 9
• 208000024714 major depressive disease Diseases 0.000 claims description 9
• 208000015122 neurodegenerative disease Diseases 0.000 claims description 9
• 208000024891 symptom Diseases 0.000 claims description 9
• 102000008186 Collagen Human genes 0.000 claims description 8
• 108010035532 Collagen Proteins 0.000 claims description 8
• 102000016359 Fibronectins Human genes 0.000 claims description 8
• 108010067306 Fibronectins Proteins 0.000 claims description 8
• 230000002159 abnormal effect Effects 0.000 claims description 8
• 229920001436 collagen Polymers 0.000 claims description 8
• 208000020016 psychiatric disease Diseases 0.000 claims description 8
• 208000019553 vascular disease Diseases 0.000 claims description 8
• 208000016285 Movement disease Diseases 0.000 claims description 7
• GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 claims description 7
• 108010004977 Vasopressins Proteins 0.000 claims description 7
• 102000002852 Vasopressins Human genes 0.000 claims description 7
• 230000036506 anxiety Effects 0.000 claims description 7
• KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 claims description 7
• 230000015572 biosynthetic process Effects 0.000 claims description 7
• 230000004064 dysfunction Effects 0.000 claims description 7
• 230000003169 placental effect Effects 0.000 claims description 7
• 230000028327 secretion Effects 0.000 claims description 7
• 229960003726 vasopressin Drugs 0.000 claims description 7
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
• 208000024827 Alzheimer disease Diseases 0.000 claims description 6
• 208000000044 Amnesia Diseases 0.000 claims description 6
• 206010012289 Dementia Diseases 0.000 claims description 6
• 208000011622 Testicular disease Diseases 0.000 claims description 6
• 208000016599 Uterine disease Diseases 0.000 claims description 6
• 230000000694 effects Effects 0.000 claims description 6
• 230000007774 longterm Effects 0.000 claims description 6
• 230000035800 maturation Effects 0.000 claims description 6
• 230000006984 memory degeneration Effects 0.000 claims description 6
• 208000023060 memory loss Diseases 0.000 claims description 6
• 230000008450 motivation Effects 0.000 claims description 6
• 230000004770 neurodegeneration Effects 0.000 claims description 6
• 239000000813 peptide hormone Substances 0.000 claims description 6
• 230000002265 prevention Effects 0.000 claims description 6
• 239000003270 steroid hormone Substances 0.000 claims description 6
• 150000003431 steroids Chemical class 0.000 claims description 6
• 208000008811 Agoraphobia Diseases 0.000 claims description 5
• 208000012639 Balance disease Diseases 0.000 claims description 5
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
• 206010019196 Head injury Diseases 0.000 claims description 5
• 208000023105 Huntington disease Diseases 0.000 claims description 5
• 206010061598 Immunodeficiency Diseases 0.000 claims description 5
• 208000029462 Immunodeficiency disease Diseases 0.000 claims description 5
• 206010033664 Panic attack Diseases 0.000 claims description 5
• 208000018737 Parkinson disease Diseases 0.000 claims description 5
• 208000003782 Raynaud disease Diseases 0.000 claims description 5
• 208000012322 Raynaud phenomenon Diseases 0.000 claims description 5
• 208000000323 Tourette Syndrome Diseases 0.000 claims description 5
• 208000016620 Tourette disease Diseases 0.000 claims description 5
• 206010047163 Vasospasm Diseases 0.000 claims description 5
• 208000029028 brain injury Diseases 0.000 claims description 5
• 210000000748 cardiovascular system Anatomy 0.000 claims description 5
• 208000029078 coronary artery disease Diseases 0.000 claims description 5
• 230000003247 decreasing effect Effects 0.000 claims description 5
• 230000003111 delayed effect Effects 0.000 claims description 5
• 239000003085 diluting agent Substances 0.000 claims description 5
• 229940079593 drug Drugs 0.000 claims description 5
• 208000024732 dysthymic disease Diseases 0.000 claims description 5
• 208000010515 dystocia Diseases 0.000 claims description 5
• 210000001508 eye Anatomy 0.000 claims description 5
• 230000001605 fetal effect Effects 0.000 claims description 5
• 210000001652 frontal lobe Anatomy 0.000 claims description 5
• 210000005095 gastrointestinal system Anatomy 0.000 claims description 5
• 206010061989 glomerulosclerosis Diseases 0.000 claims description 5
• 210000002216 heart Anatomy 0.000 claims description 5
• 208000014951 hematologic disease Diseases 0.000 claims description 5
• 208000026278 immune system disease Diseases 0.000 claims description 5
• 230000007813 immunodeficiency Effects 0.000 claims description 5
• 238000002513 implantation Methods 0.000 claims description 5
• 208000000509 infertility Diseases 0.000 claims description 5
• 230000036512 infertility Effects 0.000 claims description 5
• 231100000535 infertility Toxicity 0.000 claims description 5
• 210000004072 lung Anatomy 0.000 claims description 5
• 201000001119 neuropathy Diseases 0.000 claims description 5
• 230000007823 neuropathy Effects 0.000 claims description 5
• 210000000056 organ Anatomy 0.000 claims description 5
• 208000015124 ovarian disease Diseases 0.000 claims description 5
• 208000019906 panic disease Diseases 0.000 claims description 5
• 210000001428 peripheral nervous system Anatomy 0.000 claims description 5
• 208000033808 peripheral neuropathy Diseases 0.000 claims description 5
• 208000022821 personality disease Diseases 0.000 claims description 5
• 239000000546 pharmaceutical excipient Substances 0.000 claims description 5
• 201000000980 schizophrenia Diseases 0.000 claims description 5
• 208000020431 spinal cord injury Diseases 0.000 claims description 5
• 238000001356 surgical procedure Methods 0.000 claims description 5
• 208000020576 Adrenal disease Diseases 0.000 claims description 4
• 208000007848 Alcoholism Diseases 0.000 claims description 4
• 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 claims description 4
• 208000020925 Bipolar disease Diseases 0.000 claims description 4
• 206010012335 Dependence Diseases 0.000 claims description 4
• 208000019395 Lactation disease Diseases 0.000 claims description 4
• 206010057852 Nicotine dependence Diseases 0.000 claims description 4
• 208000025747 Rheumatic disease Diseases 0.000 claims description 4
• 208000025569 Tobacco Use disease Diseases 0.000 claims description 4
• 208000015802 attention deficit-hyperactivity disease Diseases 0.000 claims description 4
• 201000011510 cancer Diseases 0.000 claims description 4
• 210000003169 central nervous system Anatomy 0.000 claims description 4
• 230000006735 deficit Effects 0.000 claims description 4
• 201000003104 endogenous depression Diseases 0.000 claims description 4
• 230000036210 malignancy Effects 0.000 claims description 4
• 230000003307 reticuloendothelial effect Effects 0.000 claims description 4
• 230000000552 rheumatic effect Effects 0.000 claims description 4
• 208000012902 Nervous system disease Diseases 0.000 claims description 3
• 208000025966 Neurological disease Diseases 0.000 claims description 3
• 208000028683 bipolar I disease Diseases 0.000 claims description 3
• 208000025307 bipolar depression Diseases 0.000 claims description 3
• 210000005075 mammary gland Anatomy 0.000 claims description 3
• 208000000571 Fibrocystic breast disease Diseases 0.000 claims description 2
• 230000006931 brain damage Effects 0.000 claims description 2
• 231100000874 brain damage Toxicity 0.000 claims description 2
• 208000011803 breast fibrocystic disease Diseases 0.000 claims description 2
• 206010027175 memory impairment Diseases 0.000 claims description 2
• 208000019899 phobic disease Diseases 0.000 claims description 2
• 125000003275 alpha amino acid group Chemical group 0.000 claims 12
• 150000001413 amino acids Chemical class 0.000 claims 6
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 6
• 150000001408 amides Chemical class 0.000 claims 4
• 230000004071 biological effect Effects 0.000 claims 4
• 208000037849 arterial hypertension Diseases 0.000 claims 3
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 2
• 108010075254 C-Peptide Proteins 0.000 claims 2
• 101800000074 Relaxin A chain Proteins 0.000 claims 2
• 102400000834 Relaxin A chain Human genes 0.000 claims 2
• 102400000610 Relaxin B chain Human genes 0.000 claims 2
• 101710109558 Relaxin B chain Proteins 0.000 claims 2
• 230000000926 neurological effect Effects 0.000 claims 2
• 108010090955 preprorelaxin Proteins 0.000 claims 2
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 2
• 108010087851 prorelaxin Proteins 0.000 claims 2
• 208000019838 Blood disease Diseases 0.000 claims 1
• 239000004480 active ingredient Substances 0.000 claims 1
• 230000001919 adrenal effect Effects 0.000 claims 1
• 208000030270 breast disease Diseases 0.000 claims 1
• 230000003001 depressive effect Effects 0.000 claims 1
• 208000030172 endocrine system disease Diseases 0.000 claims 1
• 208000011099 endometrial disease Diseases 0.000 claims 1
• 208000018706 hematopoietic system disease Diseases 0.000 claims 1
• 230000002981 neuropathic effect Effects 0.000 claims 1
• 210000001672 ovary Anatomy 0.000 claims 1
• 238000000034 method Methods 0.000 description 5
• 201000004311 Gilles de la Tourette syndrome Diseases 0.000 description 4
• 206010040741 Sinus bradycardia Diseases 0.000 description 4
• 239000003937 drug carrier Substances 0.000 description 3
• 230000002611 ovarian Effects 0.000 description 3
• 230000000291 postprandial effect Effects 0.000 description 3
• 208000037765 diseases and disorders Diseases 0.000 description 2
• 208000024172 Cardiovascular disease Diseases 0.000 description 1
• 206010039710 Scleroderma Diseases 0.000 description 1
• 210000004100 adrenal gland Anatomy 0.000 description 1
• 208000006218 bradycardia Diseases 0.000 description 1
• 230000036471 bradycardia Effects 0.000 description 1
• 238000003745 diagnosis Methods 0.000 description 1
• 210000003754 fetus Anatomy 0.000 description 1
• 230000003176 fibrotic effect Effects 0.000 description 1
• 230000001771 impaired effect Effects 0.000 description 1
• 230000000626 neurodegenerative effect Effects 0.000 description 1
• 230000002093 peripheral effect Effects 0.000 description 1
• 206010039073 rheumatoid arthritis Diseases 0.000 description 1
• 230000005070 ripening Effects 0.000 description 1
• 230000001568 sexual effect Effects 0.000 description 1